Article
In situ tumour arrays reveal early environmental control of cancer immunity.
Nature - 1 Jun 2023
Ortiz-Muñoz Guadalupe, Brown Markus, Carbone Catherine B, Pechuan-Jorge Ximo, Rouilly Vincent, Lindberg Henrik, Ritter Alex T, Raghupathi Gautham, Sun Qianbo, Nicotra Tess, Mantri Shreya R, Yang Angela, Doerr Jonas, Nagarkar Deepti, Darmanis Spyros, Haley Benjamin, Mariathasan Sanjeev, Wang Yulei, Gomez-Roca Carlos, de Andrea Carlos Eduardo, Spigel David, Wu Thomas, Delamarre Lelia, Schöneberg Johannes, Modrusan Zora, Price Richard, Turley Shannon J, Mellman Ira, Moussion Christine
Abstract excerpt
The immune phenotype of a tumour is a key predictor of its response to immunotherapy1-4. Patients who respond to checkpoint blockade generally present with immune-inflamed5-7 tumours that are highly infiltrated by T cells. However, not all inflamed tumours respond to therapy, and even lower response rates occur among tumours that lack T cells (immune desert) or that spatially exclude T cells to the periphery of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
